# Tegileridine vs Sufentanil for Postoperative Pain Management and Gastrointestinal Recovery After Major Laparoscopic Abdominal Surgery

> **NCT07637968** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 84 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Tegileridine
- **DRUG:** Sufentanil
- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT07637968
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07637968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07637968, "Tegileridine vs Sufentanil for Postoperative Pain Management and Gastrointestinal Recovery After Major Laparoscopic Abdominal Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07637968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*